Global Neurorehabilitation Market Size study, by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), by Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cere

Global Neurorehabilitation Market Size study, by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), by Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others), by and End-User (Rehabilitation Centers, Hospitals, and Clinics) and Regional Forecasts 2021-2027

Global Neurorehabilitation Market is valued at approximately USD 1097.69 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.3 % over the forecast period 2021-2027. Neurorehabilitation is used in Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others. This device is basically used for the treatment of patients with neurological disorders such as in rehabilitation centres, hospitals and clinics. The increasing cases of neurological diseases have led to the adoption of Neurorehabilitation across the forecast period. For Instance: according to the World Health Organization in 2019, the number of neurological diseases is expanding rapidly. WHO states that globally about 264 million people are affected by depression. Bipolar disorders affect about 45 million people globally. 20 million worldwide are affected by schizophrenia. Rising product approvals by regulatory authorities anticipate the growth of Neurorehabilitation Market. Also, with the increasing investment in research and development activities, the adoption & demand for Neurorehabilitation is likely to increase the market growth during the forecast period. However, high device cost impedes the growth of the market over the forecast period of 2021-2027.

The geographical regions considered for the global Neurorehabilitation market analysis includes Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is deemed as the significant region across the globe in terms of huge market share due to the growing geriatric population and promptness & affordability of neurorehabilitation centers coupled with the well-established healthcare infrastructure and increasing cases of neurological disorders. Whereas, Asia-Pacific is also estimated to attain a maximum growth rate during 2021-2027. Factors such as rising awareness towards neurological disorders, increasing population, rising patient base and improving healthcare infrastructure would create beneficial growth forecasts for the Neurorehabilitation market across Asia-Pacific region.

Major market players included in this report are:
Bionik Laboratories Corp.
BioScience Managers Ltd (Rex Bionics Ltd)
Bioventus (Bioness Inc.)
DIH (Hocoma AG)
Ekso Bionics Holdings, Inc.
Eodyne
Neofect
Neuro Rehab VR
Reha Technology AG
ReWalk Robotics Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Neuro-Robotic Devices
Non-Invasive Stimulators
Brain-Computer Interfaces
By Application:
Brain Stroke
Parkinson's Disease
Multiple Sclerosis
Spinal Cord Injury
Traumatic Brain Injury
Cerebral Palsy
Others
By End User:
Rehabilitation Centers
Hospitals
Clinics

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Neurorehabilitation Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Bionik Laboratories Corp.
BioScience Managers Ltd (Rex Bionics Ltd)
Bioventus (Bioness Inc.)
DIH (Hocoma AG)
Ekso Bionics Holdings, Inc.
Eodyne
Neofect
Neuro Rehab VR
Reha Technology AG
ReWalk Robotics Ltd.

Please note: The single user license is non-downloadable and non-printable. Global Site license allows these actions.